OUR main post about Elsevier and Merck colluding to deceive the public was aptly titled "The Pharmaceutical Cartel". A lot people are not aware of ethical issues that surround this industry, where intellectual monopolies are basically used to monetise death [1, 2, 3]. Considering the nature of what Merck has been doing, it is not entirely surprising that Microsoft shakes its hands. It's a lovely pairing.
Microsoft is getting into genetic data management through an agreement with Merck.
Chaib says media will be excluded from the meeting.
In the case of cocaine there is an even more striking precedent for evidence being ignored: the World Health Organisation (WHO) conducted what is probably the largest ever study of global use. In March 1995 they released a briefing kit which summarised their conclusions, with some tantalising bullet points.
"Health problems from the use of legal substances, particularly alcohol and tobacco, are greater than health problems from cocaine use," they said. "Cocaine-related problems are widely perceived to be more common and more severe for intensive, high-dosage users and very rare and much less severe for occasional, low-dosage users."
[...]
At the point where mild cocaine use was described in positive tones the Americans presumably blew some kind of outrage fuse. This report was never published because the US representative to the WHO threatened to withdraw US funding for all its research projects and interventions unless the organisation "dissociated itself from the study" and cancelled publication. According to the WHO this document does not exist, (although you can read a leaked copy at www.tdpf.org.uk/WHOleaked.pdf).
Remember how Elsevier and Merck were caught putting out a fake journal that had articles favoring Merck drugs, implying peer reviewed articles that weren't? Soon afterwards, it came out that Elsevier had a whole division for such things. However, following an internal investigation, it looks like Elsevier is backtracking a bit and saying that, while the group's practices were problematic, most weren't as egregious as the "Australasian Journal of Bone and Joint Medicine (AJBJM)" that was created by Merck and Elsevier.
Remember a week ago when we wrote about pharma giant Merck and publishing giant Elsevier working together to publish a fake journal that talked up various Merck drugs and was used by doctors to show that the drugs were safe and useful?
--Alfred North Whitehead